Apr 18 |
Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
Apr 12 |
Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)
|
Apr 11 |
Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation
|
Apr 9 |
11 Best Biotech ETFs To Buy
|
Apr 8 |
Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera™ Heart dd-cfDNA Test for Heart Transplant Recipients
|
Apr 5 |
Cracking The Code: Understanding Analyst Reviews For Natera
|
Apr 5 |
Looking Into Natera's Recent Short Interest
|
Apr 5 |
Natera upgraded at Bernstein on gross margin trajectory
|
Apr 5 |
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
|
Apr 5 |
Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive?
|